Education
About Us
Working with TipRanks
Follow Us
Cybin (TSE:CYBN)
NEO-L:CYBN
Earnings Data
Report Date
Feb 17, 2026Before Open (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-1.06Last Year’s EPS
-0.53Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects a company making significant progress in advancing its clinical programs and strengthening its financial position, despite facing challenges such as leadership transition and increased expenses. The overall sentiment is balanced, with solid achievements in clinical and operational fronts but offset by financial and leadership concerns.Company Guidance
Advancement in Clinical Programs
CYB003 Phase III program for major depressive disorder and CYB004 Phase II program for generalized anxiety disorder are progressing as planned. The CYB004 study completed enrollment and is on track for a top line readout in the first calendar quarter of 2026.
Successful Financing and Strengthened Capital Position
Closed a $175 million financing, providing flexibility to execute plans and retire convertible debentures. Ended the quarter with $83.8 million in cash, cash equivalents, and investments.
Global Study Expansion
EMBRACE Phase III study for CYB003 has been cleared to commence in the United States, U.K., multiple European Union countries, and Australia.
Operational and Commercial Readiness
Partnership with Thermo Fisher for manufacturing and Osmind for point-of-care software to enhance clinic workflow and data management.
Positive Market and Investor Confidence
Participation from prominent institutional healthcare investors in recent financing reflects confidence in Cybin's science and programs.
TSE:CYBN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:CYBN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | C$0.14 | C$0.14 | 0.00% |
Aug 13, 2025 | C$0.14 | C$0.14 | 0.00% |
Feb 11, 2025 | C$0.14 | C$0.14 | 0.00% |
Nov 13, 2024 | C$0.14 | C$0.14 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cybin (TSE:CYBN) report earnings?
Cybin (TSE:CYBN) is schdueled to report earning on Feb 17, 2026, Before Open (Confirmed).
What is Cybin (TSE:CYBN) earnings time?
Cybin (TSE:CYBN) earnings time is at Feb 17, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:CYBN EPS forecast?
TSE:CYBN EPS forecast for the fiscal quarter 2026 (Q3) is -1.06.